| Literature DB >> 9817182 |
F J Meyer1, M Wencker, H Teschler, H Steveling, J Sennekamp, U Costabel, N Konietzko.
Abstract
A 44 yr-old female with severe pulmonary emphysema and reduced alpha-1-protease inhibitor (alpha1-PI) serum levels developed an acute anaphylactic reaction following the third intravenous infusion of human alpha1-PI which was administered to prevent the progression of pulmonary emphysema. Specific immunoglobulin E-antibodies against human alpha1-PI could be demonstrated in the patient's serum using an enzyme allergosorbent test. Because of the risk of further severe anaphylactic reaction, the replacement therapy with alpha1-PI was discontinued. Physicians should be aware of this rare complication.Entities:
Mesh:
Substances:
Year: 1998 PMID: 9817182 DOI: 10.1183/09031936.98.12040996
Source DB: PubMed Journal: Eur Respir J ISSN: 0903-1936 Impact factor: 16.671